Navigation Links
Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
Date:1/16/2008

mmatory drug target. At the same time, they also protect cells and tissues against inflammatory damage. Morria is determined to become a pivotal player in the anti-inflammatory drug market by developing and commercializing novel drugs for acute pulmonary and gastro-intestinal inflammatory diseases. For more information, please visit http://www.morria.com.

This is not an invitation nor is it an offer to purchase or subscribe for shares. This release is only intended for persons falling within the exception set out in regulation 47 of the Financial Promotion order -- Persons in the business of disseminating information.

Contact:

Meghan Feeks

+1-212-827-0020

mfeeks@rlcinc.com


'/>"/>
SOURCE Morria Biopharmaceuticals Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
4. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
5. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... LAKE ZURICH, Ill., Dec. 15 Fenwal Inc., ... and availability for patient care, reiterated its commitment to ... collect lifesaving blood products, despite a new lawsuit filed ... The Fenwal® Alyx® system, introduced in 2003, is an ... of red cells from a single donor in about ...
(Date:12/15/2009)... 15 West Pharmaceutical Services, Inc. (NYSE: ... Directors has approved payment of the first-quarter 2010 cash ... paid on February 3, 2010 to shareholders of record ... ,, West is a global manufacturer of components ... seals for vials, and closures and disposable components used ...
(Date:12/15/2009)... Dec. 15 Dakim, Inc. and Alzheimer,s Weekly ... Loved Ones, Brain Health Contest, designed to help five ... dementia and Alzheimer,s disease. All five winners will receive ... specifically to help seniors preserve their brain health and ... senior living communities across the country. ,, ...
Breaking Medicine Technology:Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 35 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Vitality Health LLC Joins HealthySkinPortal Network 55704 1Vitality Health LLC Joins HealthySkinPortal Network 55704 2Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 1Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 2Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 3Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 4Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barc 4921 1Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barc 4921 2Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barc 4921 3
(Date:12/15/2009)... risk, research finds , , TUESDAY, Dec. 15 (HealthDay News) ... regulates appetite, may guard against Alzheimer,s disease, new research ... may be one of many agents that we use ... study author Dr. Sudha Seshadri, an associate professor of ... may be one of many markers that we measure ...
(Date:12/15/2009)... have lower strength than needed for protection, CDC says, ... children,s doses of H1N1 swine flu vaccine have been ... lost some potency, federal health officials said Tuesday. , ... Prevention, the company,s routine testing of the vaccine for ... that four batches had lower than required potency levels. ...
(Date:12/15/2009)... cancer tests promised but not delivered ,, ... calls on Congress to ensure that healthcare reform ... currently required of insurance companies in 37 states. ... those segments of the population and individuals who ... men and men who have a family history ...
(Date:12/15/2009)... PARK, Calif., Dec. 15 ... position in the pharmaceutical and bio-tech research ... Marketing Research). Over the past 11 years ... the Physicians Consulting Network (PCN®), which now ... professionals covering both primary care and hard-to-reach ...
(Date:12/15/2009)... 15 Team In Training (TNT), The ... charity sports training program, has reached a remarkable ... cancer research and patient services. ,, For more ... charity endurance sports training program, preparing amateurs and ... triathlon, 100-mile century cycle ride or hike adventure. ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3
... list comes as a surprise to infectious disease experts ... air travelers with suspected or confirmed infectious tuberculosis were ... Board" list in the first year of its existence, ... the Aviation and Transportation Security Act of 2001, the ...
... Make Leaders More Effective Over Their,Careers, GREENSBORO, N.C., ... when one is moving from good stress,to bad stress ... difference,according to research from the Center for Creative Leadership ... When one,s resources meet or exceed the demands put ...
... rates at adequate levels have prompted the nation,s ... raise the public,s,confidence in vaccines. The Immunization Alliance ... public to work together to,preserve the health of ... made up of medical, public health and parent,organizations, ...
... Cares/Equity Fights AIDS, NEW YORK, Sept. 18 ... is participating in the Annual Broadway Flea Market to ... 21, from,10:00am to 7:00pm. Shubert Alley and 44th Street, ... Flea Market brings out the biggest and brightest stars,from ...
... Sept. 18 Today US Oncology, Inc., which,supports ... the appointment of Michael A. Sicuro as Executive ... Sicuro will lead and manage,the finance function and ... operational, and transactional issues, including accounting,financial reporting, treasury, ...
... If you really want to curb your teens, chances of ... drinking. According to a new Iowa State University study, the ... alcohol use. , But beware. The opposite is also true. ... the teens developed the self-view that they were likely to ...
Other Medicine News:Health News:U.S. Barred 33 TB-Infected People From Flying Over Past Year 2Health News:U.S. Barred 33 TB-Infected People From Flying Over Past Year 3Health News:Distinguishing Between Good and Bad Stress is Key for Leaders 2Health News:Distinguishing Between Good and Bad Stress is Key for Leaders 3Health News:Distinguishing Between Good and Bad Stress is Key for Leaders 4Health News:New Immunization Alliance Issues National Call to Action 2Health News:New Immunization Alliance Issues National Call to Action 3Health News:Grey New York Appears at the Broadway Flea Market 2Health News:US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer 2Health News:Iowa State study finds mom's beliefs may impact their kids' alcohol use 2Health News:Iowa State study finds mom's beliefs may impact their kids' alcohol use 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: